Integration of EHR and ECG Data for Predicting Paroxysmal Atrial Fibrillation in Stroke Patients.

IF 3.7 3区 医学 Q2 ENGINEERING, BIOMEDICAL
Alireza Vafaei Sadr, Manvita Mareboina, Diana Orabueze, Nandini Sarkar, Seyyed Sina Hejazian, Ajith Vemuri, Ravi Shah, Ankit Maheshwari, Ramin Zand, Vida Abedi
{"title":"Integration of EHR and ECG Data for Predicting Paroxysmal Atrial Fibrillation in Stroke Patients.","authors":"Alireza Vafaei Sadr, Manvita Mareboina, Diana Orabueze, Nandini Sarkar, Seyyed Sina Hejazian, Ajith Vemuri, Ravi Shah, Ankit Maheshwari, Ramin Zand, Vida Abedi","doi":"10.3390/bioengineering12090961","DOIUrl":null,"url":null,"abstract":"<p><p>Predicting paroxysmal atrial fibrillation (PAF) is challenging due to its transient nature. Existing methods often rely solely on electrocardiogram (ECG) waveforms or Electronic Health Record (EHR)-based clinical risk factors. We hypothesized that explicitly balancing the contributions of these heterogeneous data sources could improve prediction accuracy. We developed a Transformer-based deep learning model that integrates 12-lead ECG signals and 47 structured EHR variables from 189 patients with cryptogenic stroke, including 49 with PAF. By systematically varying the relative contributions of ECG and EHR data, we identified an optimal ratio for prediction. Best performance (accuracy: 0.70, sensitivity: 0.72, specificity: 0.87, Area Under Curve - Receiver Operating Characteristics (AUROC): 0.65, Area Under the Precision-Recall Curve (AUPRC): 0.43) was achieved using a 5-fold cross-validation when EHR data contributed one-third and ECG data two-thirds of the model's input. This multimodal approach outperformed unimodal models, improving accuracy by 35% over EHR-only and 5% over ECG-only methods. Our results support the value of combining ECG and structured EHR information to improve accuracy and sensitivity in this pilot cohort, motivating validation in larger studies.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 9","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12467541/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12090961","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Predicting paroxysmal atrial fibrillation (PAF) is challenging due to its transient nature. Existing methods often rely solely on electrocardiogram (ECG) waveforms or Electronic Health Record (EHR)-based clinical risk factors. We hypothesized that explicitly balancing the contributions of these heterogeneous data sources could improve prediction accuracy. We developed a Transformer-based deep learning model that integrates 12-lead ECG signals and 47 structured EHR variables from 189 patients with cryptogenic stroke, including 49 with PAF. By systematically varying the relative contributions of ECG and EHR data, we identified an optimal ratio for prediction. Best performance (accuracy: 0.70, sensitivity: 0.72, specificity: 0.87, Area Under Curve - Receiver Operating Characteristics (AUROC): 0.65, Area Under the Precision-Recall Curve (AUPRC): 0.43) was achieved using a 5-fold cross-validation when EHR data contributed one-third and ECG data two-thirds of the model's input. This multimodal approach outperformed unimodal models, improving accuracy by 35% over EHR-only and 5% over ECG-only methods. Our results support the value of combining ECG and structured EHR information to improve accuracy and sensitivity in this pilot cohort, motivating validation in larger studies.

整合EHR和ECG数据预测脑卒中患者阵发性心房颤动。
由于阵发性心房颤动(PAF)的短暂性,其预测具有挑战性。现有的方法通常仅仅依赖于心电图(ECG)波形或基于电子健康记录(EHR)的临床危险因素。我们假设明确地平衡这些异构数据源的贡献可以提高预测的准确性。我们开发了一个基于transformer的深度学习模型,该模型集成了来自189名隐源性卒中患者(包括49名PAF患者)的12导联ECG信号和47个结构化EHR变量。通过系统地改变心电图和电子病历数据的相对贡献,我们确定了一个最佳的预测比例。当电子病历数据占模型输入的三分之一,心电数据占模型输入的三分之二时,使用5倍交叉验证获得了最佳性能(准确性:0.70,灵敏度:0.72,特异性:0.87,曲线下面积-接收者工作特征(AUROC): 0.65,精确度-召回曲线下面积(AUPRC): 0.43)。这种多模式方法优于单模式模型,比仅ehr方法提高了35%的准确性,比仅ecg方法提高了5%。我们的研究结果支持结合ECG和结构化EHR信息的价值,以提高该试点队列的准确性和敏感性,激励在更大规模的研究中进行验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bioengineering
Bioengineering Chemical Engineering-Bioengineering
CiteScore
4.00
自引率
8.70%
发文量
661
期刊介绍: Aims Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal: ● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings. ● Manuscripts regarding research proposals and research ideas will be particularly welcomed. ● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material. ● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds. Scope ● Bionics and biological cybernetics: implantology; bio–abio interfaces ● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices ● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc. ● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology ● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering ● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation ● Translational bioengineering
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信